Cardiff Oncology (CRDF) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Cardiff Oncology (CRDF) over the last 15 years, with Q3 2025 value amounting to -$11.3 million.
- Cardiff Oncology's Profit After Tax rose 503.58% to -$11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.4 million, marking a year-over-year decrease of 1731.23%. This contributed to the annual value of -$45.4 million for FY2024, which is 962.81% down from last year.
- Latest data reveals that Cardiff Oncology reported Profit After Tax of -$11.3 million as of Q3 2025, which was up 503.58% from -$13.9 million recorded in Q2 2025.
- In the past 5 years, Cardiff Oncology's Profit After Tax ranged from a high of -$5.2 million in Q1 2021 and a low of -$13.9 million during Q2 2025
- For the 5-year period, Cardiff Oncology's Profit After Tax averaged around -$10.1 million, with its median value being -$10.4 million (2022).
- In the last 5 years, Cardiff Oncology's Profit After Tax tumbled by 11226.11% in 2022 and then soared by 1079.93% in 2024.
- Over the past 5 years, Cardiff Oncology's Profit After Tax (Quarter) stood at -$9.4 million in 2021, then increased by 7.89% to -$8.7 million in 2022, then decreased by 7.36% to -$9.3 million in 2023, then fell by 26.24% to -$11.8 million in 2024, then increased by 4.49% to -$11.3 million in 2025.
- Its Profit After Tax was -$11.3 million in Q3 2025, compared to -$13.9 million in Q2 2025 and -$13.4 million in Q1 2025.